Cargando…
Targeting Myeloid-Derived Suppressor Cells Is a Novel Strategy for Anti-Psoriasis Therapy
Psoriasis is a common immune-mediated, chronic inflammatory genetic-related disease that affects patients' quality of life. Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of progenitor and immature myeloid cells which are expanded in psoriatic skin lesions and periphera...
Autores principales: | Chen, Chao, Tan, Lirong, Zhu, Wu, Lei, Li, Kuang, Yehong, Liu, Panpan, Li, Jie, Chen, Xiang, Peng, Cong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338977/ https://www.ncbi.nlm.nih.gov/pubmed/32684837 http://dx.doi.org/10.1155/2020/8567320 |
Ejemplares similares
-
Acitretin Promotes the Differentiation of Myeloid-Derived Suppressor Cells in the Treatment of Psoriasis
por: Liu, Panpan, et al.
Publicado: (2021) -
Lysophosphatidic acid mediates the pathogenesis of psoriasis by activating keratinocytes through LPAR5
por: Lei, Li, et al.
Publicado: (2021) -
Skin and Gut Microbiome in Psoriasis: Gaining Insight Into the Pathophysiology of It and Finding Novel Therapeutic Strategies
por: Chen, Lihui, et al.
Publicado: (2020) -
The role of Langerhans cells in epidermal homeostasis and pathogenesis of psoriasis
por: Yan, Bei, et al.
Publicado: (2020) -
CD147 Facilitates the Pathogenesis of Psoriasis through Glycolysis and H3K9me3 Modification in Keratinocytes
por: Chen, Chao, et al.
Publicado: (2023)